InsiderSignal.AI

InsiderSignal.ai

MRAI - Marpai, Inc.

Insider Purchase by Lamendola Damien (CEO, 10%)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

4 months ago, Lamendola Damien, serving as CEO, 10% owner at Marpai, Inc. (MRAI), purchased 147,058 shares at $1.36 per share, for a total transaction value of $199,999.00. Following this transaction, Lamendola Damien now holds 8,151,567 shares of MRAI.

This purchase represents a 2.00% increase in Lamendola Damien's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, September 30, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 2, 2025, 2 days after the trade was made.

Marpai, Inc. operates in the HEALTHCARE sector, specifically within the HEALTHCARE PLANS industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Lamendola Damien

CEO, 10%

Damien Lamendola is a seasoned healthcare executive serving as Chief Executive Officer and Director of Marpai, Inc. (MRAI) since November 2023, after joining the board in April 2021.[[1]](https://www.zoominfo.com/p/Damien-Lamendola/668956740)[[2]](https://www.marpaihealth.com/about/)[[3]](https://simplywall.st/stocks/us/insurance/otc-mrai/marpai/management) He owns approximately 37.25% of the company's shares, valued at around $9.8 million, and has recently facilitated investments through his controlled entity, HillCour Investment Fund, LLC, including a $200,000 private placement in October 2025 representing a 10% ownership stake.[[3]](https://simplywall.st/stocks/us/insurance/otc-mrai/marpai/management)[[4]](https://www.prnewswire.com/news-releases/marpai-inc-receives-additional-200-000-investment-from-damien-lamendolas-hillcour-investment-fund-302576145.html) Lamendola founded Continental Benefits in 2013, serving as CEO until 2019, and has been President of HillCour Holding Corporation (formerly Welldyne Holding Corp.) since March 2002, overseeing operations in pharmacy benefits and healthcare services; he previously led WellDyne as CEO from 2006 and founded it in 2002.[[1]](https://www.zoominfo.com/p/Damien-Lamendola/668956740)[[2]](https://www.marpaihealth.com/about/)[[5]](https://ir.marpaihealth.com/2023-11-06-Marpai-Names-Damien-Lamendola-as-Chief-Executive-Officer-to-Drive-the-Next-Phase-of-its-Growth) Earlier roles include marketing positions at NutraSweet and Neotame.[[1]](https://www.zoominfo.com/p/Damien-Lamendola/668956740) He holds a B.S. in Chemical Engineering from McNeese State University and an M.B.A. from Washington University.[[1]](https://www.zoominfo.com/p/Damien-Lamendola/668956740)[[2]](https://www.marpaihealth.com/about/)

View full insider profile →

Trade Price

$1.36

Quantity

147,058

Total Value

$199,999.00

Shares Owned

8,151,567

Trade Date

Tuesday, September 30, 2025

145 days ago

SEC Filing Date

Thursday, October 2, 2025

Filed 2 days after trade

HEALTHCAREHEALTHCARE PLANS

About Marpai, Inc.

Company Overview

No company information available
View news mentioning MRAI

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/591720

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime